Monsanto (NYSE:MON)‘s stock had its “market perform” rating reissued by research analysts at Wells Fargo & Co in a report released on Wednesday, The Fly reports. They presently have a $128.00 target price on the basic materials company’s stock, up from their previous target price of $118.00. Wells Fargo & Co’s target price points to a potential upside of 6.08% from the company’s previous close.

Other equities analysts have also issued research reports about the company. BMO Capital Markets reissued a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research report on Thursday, October 5th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a research report on Tuesday. Barclays reissued an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a research report on Wednesday, November 15th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $127.30.

Shares of Monsanto (NYSE MON) traded up $1.80 during trading hours on Wednesday, reaching $120.66. The company’s stock had a trading volume of 6,990,000 shares, compared to its average volume of 3,070,000. Monsanto has a fifty-two week low of $106.97 and a fifty-two week high of $122.79. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. The stock has a market cap of $53,110.00, a price-to-earnings ratio of 22.30, a price-to-earnings-growth ratio of 1.70 and a beta of 1.04.

Monsanto (NYSE:MON) last issued its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The business had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.77 billion. During the same period last year, the firm posted $0.21 EPS. Monsanto’s quarterly revenue was up .3% compared to the same quarter last year. sell-side analysts anticipate that Monsanto will post 5.76 EPS for the current year.

In other news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.79% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Monsanto by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock valued at $3,636,697,000 after purchasing an additional 784,418 shares during the last quarter. BlackRock Inc. grew its stake in shares of Monsanto by 6.5% during the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock valued at $3,302,038,000 after acquiring an additional 1,705,439 shares during the period. State Street Corp grew its stake in shares of Monsanto by 0.6% during the 2nd quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock valued at $2,399,965,000 after acquiring an additional 122,814 shares during the period. Capital International Investors grew its stake in shares of Monsanto by 10.3% during the 3rd quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock valued at $1,119,650,000 after acquiring an additional 872,377 shares during the period. Finally, Northern Trust Corp grew its stake in shares of Monsanto by 0.7% during the 2nd quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after acquiring an additional 47,725 shares during the period. 75.37% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Co Reiterates Market Perform Rating for Monsanto (MON)” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/wells-fargo-co-reiterates-market-perform-rating-for-monsanto-mon/1814665.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

The Fly

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.